Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 212895

Expand all

CONJUPRI (LEVAMLODIPINE MALEATE)
EQ 2.5MG BASE
Marketing Status: Prescription

Active Ingredient: LEVAMLODIPINE MALEATE
Proprietary Name: CONJUPRI
Dosage Form; Route of Administration: TABLET; ORAL
Strength: EQ 2.5MG BASE
Reference Listed Drug: Yes
Reference Standard: No
TE Code: 
Application Number: N212895
Product Number: 002
Approval Date: Dec 19, 2019
Applicant Holder Full Name: CSPC OUYI PHARMACEUTICAL CO LTD
Marketing Status:  Prescription
Patent and Exclusivity Information

CONJUPRI (LEVAMLODIPINE MALEATE)
EQ 5MG BASE
Marketing Status: Prescription

Active Ingredient: LEVAMLODIPINE MALEATE
Proprietary Name: CONJUPRI
Dosage Form; Route of Administration: TABLET; ORAL
Strength: EQ 5MG BASE
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: 
Application Number: N212895
Product Number: 003
Approval Date: Dec 19, 2019
Applicant Holder Full Name: CSPC OUYI PHARMACEUTICAL CO LTD
Marketing Status:  Prescription
Patent and Exclusivity Information

CONJUPRI (LEVAMLODIPINE MALEATE)
EQ 1.25MG BASE
Marketing Status: Discontinued

Active Ingredient: LEVAMLODIPINE MALEATE
Proprietary Name: CONJUPRI
Dosage Form; Route of Administration: TABLET; ORAL
Strength: EQ 1.25MG BASE
Reference Listed Drug: Yes
Reference Standard: No
TE Code: 
Application Number: N212895
Product Number: 001
Approval Date: Dec 19, 2019
Applicant Holder Full Name: CSPC OUYI PHARMACEUTICAL CO LTD
Marketing Status:  Discontinued
Patent and Exclusivity Information